🇺🇸 FDA
Patent

US 7462625

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

granted A61KA61K31/513A61P

Quick answer

US patent 7462625 (Gonadotropin-releasing hormone receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/513, A61P, A61P1/04, A61P13/08